This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...
Dublin, March 15, 2018 (GLOBE NEWSWIRE) -- The "Uveitis Therapeutics in Asia-Pacific Markets to 2023 - Increasing Prevalence, Continued Uptake of Biologics and Novel Pipeline Drugs to Drive the Market ...
Dublin, Jan. 15, 2026 (GLOBE NEWSWIRE) -- The "Uveitis - Global Clinical Trials Review, 2025" report has been added to ResearchAndMarkets.com's offering. The clinical trial report provides an overview ...
A team led by UCL researchers with Great Ormond Street Hospital (GOSH) and Moorfields Eye Hospital, found B cells—alongside T ...
An investigational Janus kinase 1 (JAK1) preferential inhibitor reduced the risk of treatment failure among patients with active noninfectious uveitis, the phase II randomized HUMBOLDT trial showed.
Early-onset, chronic nonanterior uveitis in children increases the risk of ocular complications, with 44.3% experiencing issues like cataracts and macular edema. Persistent chronic uveitis is a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results